John Gerich

4.2k total citations · 3 hit papers
11 papers, 3.1k citations indexed

About

John Gerich is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, John Gerich has authored 11 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in John Gerich's work include Diabetes Treatment and Management (6 papers), Diabetes Management and Research (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). John Gerich is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diabetes Management and Research (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). John Gerich collaborates with scholars based in United States, Italy and Canada. John Gerich's co-authors include Julio Rosenstock, Matthew C. Riddle, Asimina Mitrakou, Theo van Haeften, W. Renn, Walkyria de Paula Pimenta, Trond Jenssen, H Yki-Järvinen, Michael Stümvoll and Philip Raskin and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Transplantation.

In The Last Decade

John Gerich

11 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Treat-to-Target Trial

2003 1.2k citations Matthew C. Riddle, Julio Rosenstock et al. Diabetes Care profile →
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

2000 826 citations Michael Stümvoll, Asimina Mitrakou et al. Diabetes Care profile →
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

2009 707 citations Bernard Zinman, John Gerich et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Gerich United States	10	2.5k	941	937	512	330	11	3.1k
Steven C. Griffen United States	28	1.8k 0.7×	888 0.9×	1.1k 1.2×	427 0.8×	707 2.1×	42	3.0k
Carola Saloranta Finland	27	1.4k 0.6×	982 1.0×	849 0.9×	828 1.6×	788 2.4×	39	3.0k
Robert G. Brodows United States	27	3.2k 1.3×	1.4k 1.5×	1.3k 1.4×	229 0.4×	478 1.4×	50	3.8k
Takeshi Kurose Japan	27	1.2k 0.5×	801 0.9×	685 0.7×	239 0.5×	374 1.1×	76	2.1k
H Yki-Järvinen Finland	26	1.8k 0.7×	996 1.1×	706 0.8×	325 0.6×	764 2.3×	38	3.3k
Stanley S. Schwartz United States	21	1.4k 0.6×	671 0.7×	573 0.6×	257 0.5×	337 1.0×	64	2.3k
Dana K. Andersen United States	23	1.3k 0.5×	830 0.9×	1.2k 1.3×	236 0.5×	781 2.4×	52	2.8k
Frank Vercruysse United States	19	1.7k 0.7×	583 0.6×	931 1.0×	199 0.4×	261 0.8×	24	2.1k
Steven C. Elbein United States	28	1.0k 0.4×	1.2k 1.3×	867 0.9×	804 1.6×	859 2.6×	63	3.1k
M. Nattrass United Kingdom	26	1.1k 0.4×	450 0.5×	536 0.6×	427 0.8×	452 1.4×	125	2.1k

Countries citing papers authored by John Gerich

Since Specialization

Citations

This map shows the geographic impact of John Gerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Gerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Gerich more than expected).

Fields of papers citing papers by John Gerich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Gerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Gerich. The network helps show where John Gerich may publish in the future.

Co-authorship network of co-authors of John Gerich

This figure shows the co-authorship network connecting the top 25 collaborators of John Gerich. A scholar is included among the top collaborators of John Gerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Gerich. John Gerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Alsahli, Mazen & John Gerich. (2015). Hypoglycemia in Patients with Diabetes and Renal Disease. Journal of Clinical Medicine. 4(5). 948–964. 89 indexed citations

2.

Zinman, Bernard, John Gerich, John B. Buse, et al.. (2009). Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD). Diabetes Care. 32(7). 1224–1230. 707 indexed citations breakdown →

3.

Gerich, John, et al.. (2006). Fluctuation of Serum Basal Insulin Levels Following Single and Multiple Dosing of Insulin Glargine. Diabetes Technology & Therapeutics. 8(2). 237–243. 34 indexed citations

4.

Riddle, Matthew C., et al.. (2003). The Treat-to-Target Trial. Diabetes Care. 26(11). 3080–3086. 1154 indexed citations breakdown →

5.

Gerich, John. (2001). Matching treatment to pathophysiology in type 2 diabetes. Clinical Therapeutics. 23(5). 646–659. 25 indexed citations

6.

Stümvoll, Michael, Asimina Mitrakou, Walkyria de Paula Pimenta, et al.. (2000). Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.. Diabetes Care. 23(3). 295–301. 826 indexed citations breakdown →

7.

Meyer, Christian, Bernhard J. Hering, Heide Brandhorst, et al.. (1998). IMPROVED GLUCOSE COUNTERREGULATION AND AUTONOMIC SYMPTOMS AFTER INTRAPORTAL ISLET TRANSPLANTS ALONE IN PATIENTS WITH LONG-STANDING TYPE I DIABETES MELLITUS1. Transplantation. 66(2). 233–240. 46 indexed citations

8.

Gerich, John. (1996). Pathogenesis and Treatment of Type 2 (Noninsulin-Dependent) Diabetes Mellitus (NIDDM). Hormone and Metabolic Research. 28(9). 404–412. 31 indexed citations

9.

Mitrakou, Asimina, Carmine G. Fanelli, Th.F. Veneman, et al.. (1993). Reversibility of Unawareness of Hypoglycemia in Patients with Insulinomas. New England Journal of Medicine. 329(12). 834–839. 144 indexed citations

10.

Havel, Richard J., et al.. (1980). Pancreatic Alpha and Beta Cell Function in Familial Dysbetalipoproteinemia. Hormone and Metabolic Research. 12(9). 421–425. 3 indexed citations

11.

Lewis, Stephen B., et al.. (1977). Insulin-Glucose Dynamics during Flow-Through Perfusion of the Isolated Rat Hindlimb. Hormone and Metabolic Research. 9(3). 190–195. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact